J Neurol Surg B Skull Base
DOI: 10.1055/a-2693-1905
Original Article

Bioengineered Materials for Skull Base Reconstruction—Current Clinical Applications: Systematic Review and Meta-analysis

1   Department of Neurosurgery, CHU de Québec – Université Laval, Québec, QC, Canada
2   Department of Postgraduate Program in Medicine: Surgical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
,
Marc-Olivier Comeau
3   Faculté de Médecine, Université Laval, Québec, QC, Canada
,
Rodrigo Ness
4   Medical School, Universidade Federal de Pelotas, Pelotas, RS, Brazil
,
Fernando Gomes
5   Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
Frederico de Lima Gibbon
2   Department of Postgraduate Program in Medicine: Surgical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
,
Pierre-Olivier Champagne
1   Department of Neurosurgery, CHU de Québec – Université Laval, Québec, QC, Canada
› Institutsangaben
Preview

Abstract

Introduction

Skull base reconstruction (SBR) is a crucial aspect of open and endoscopic skull base surgery. Currently, multilayer reconstruction with vascularized tissues is the standard technique. Despite advancements, complications such as postoperative cerebrospinal fluid leaks (PO-CSF-L) and infections persist. Bioengineered materials (BEM) have emerged for SBR, showing promising results.

Methods

A systematic review was conducted using Embase, PubMed, Scopus, and Cochrane databases. We performed a proportional meta-analysis of studies utilizing BEM for SBR and a comparative analysis with control groups that underwent SBR without biomaterials. The odds ratio assessed treatment effects for binary outcomes.

Results

From 1,075 potential articles, 14 met the inclusion criteria. Five BEM were identified: hydroxyapatite (HXA), leukocyte–platelet-rich fibrin (L-PFR), collagen matrix (CM), polyglycolic acid (PGA), and porous polyethylene (PP). The analysis included 1,960 patients, with 1,570 in experimental groups using BEM. Pooled data indicated a PO-CSF-L proportion of 0.02% (95% CI: 0.01–0.03%), postoperative CSF diversion (PO-CSF-d) at 0.01% (95% CI: 0.00–0.04), and PO infection at 0.02% (95% CI: 0.00–0.05%). Common effect models showed that CM had a lower total PO infection rate (0.01; 95% CI: 0.00–0.01, p = 0.0006) compared with HXA (0.08; 95% CI: 0.05–0.11, p = 0.0007). Comparative analysis demonstrated lower odds of PO-CSF-L (OR 0.37; 95% CI: 0.15–0.89, p = 0.026) and infections (OR 0.47; 95% CI: 0.13–1.47, p = 0.264) in patients with BEM.

Conclusion

Our results indicate that bioengineered materials are viable for skull base reconstruction, associated with low rates of postoperative CSF leaks, diversions, and infections.

Supplementary Material



Publikationsverlauf

Eingereicht: 06. Mai 2025

Angenommen: 31. August 2025

Accepted Manuscript online:
01. September 2025

Artikel online veröffentlicht:
11. September 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany